AMAG Pharma (AMAG) Reports Q1 Loss of $0.72/sh
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
License fee and other collaboration revenues: 40K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
License fee and other collaboration revenues: 40K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q1 EPS of ($0.72), versus ($3.54) reported last year. Revenue for the quarter came in at $68.7 million versus the consensus estimate of $64.82 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
